GARDEN GROVE, Calif., July 19, 2011 /PRNewswire/ -- HYCOR Biomedical, Inc., a leading manufacturer and marketer of in vitro diagnostic products, today announced that Sean-Xavier Neath, M.D., Ph.D., has been appointed as Chief Medical Officer (CMO). In this role, Dr. Neath will support the company as it works to expand its product lines and provide additional support for customers.
"We are pleased to welcome Dr. Neath to the HYCOR team and are confident he will have great impact on key areas of our business," said Dick Aderman, CEO, HYCOR. "Given his diverse background in the academic, clinical and business sectors we look forward to learning from his experience and leveraging his unique perspective during this important time of growth for the company."
Dr. Neath brings extensive knowledge and leadership in the pharmaceutical and diagnostics industries having served in medical affairs positions for a number of leading companies, including BRAHMS USA and Biosite. During his time at BRAHMS USA, Dr. Neath lead new product development strategies, including clinical trial design and regulatory submission planning. In addition, Dr. Neath was responsible for medical education, marketing and reimbursement program development. In his role at Biosite, Dr. Neath provided strategic counsel to the business development, marketing, sales and R&D teams and also developed educational curricula for physician clients.
"I'm pleased to join the HYCOR team to identify product development opportunities and work to expand the customer support services that HYCOR customers value most," said Dr. Neath.
About HYCOR Biomedical, Inc.
Founded in 1981, HYCOR is a global manufacturer and marketer of in vitro diagnostics products. Since its founding, HYCOR has expanded its presence into urinalysis, allergy and autoimmune products used in clinical laboratories, hospitals and doctors' offices worldwide. Among its products, HYCOR markets t